Fas | OKDB#: 299 |
Symbols: | TNFRSF6 | Species: | human | ||
Synonyms: | APOPTOSIS ANTIGEN 1, APT1| FAS ANTIGEN| SURFACE ANTIGEN APO1, APO1| CD95| | Locus: | 10q24.1 in Homo sapiens | HPMR |
For retrieval of Nucleotide and Amino Acid sequences please go to:
OMIM
Entrez Gene
Mammalian Reproductive Genetics Endometrium Database Resource Orthologous Genes UCSC Genome Browser GEO Profiles new! Amazonia (transcriptome data) new! R-L INTERACTIONS MGI |
General Comment |
The Fas antigen is a cell surface receptor that triggers apoptosis when bound to Fas ligand (FasL)Atresia found in early antral rat follicles positive for Fas and FasL, however, atresia and granulosa cell apoptosis noted in large antral and preovulatory follicles showed Fas, but not FasL (Kim et al.,1999). IFN increases Fas antigen expression (Quirk et al.,1997) Coculturing IFN-pretreated granulosa cells with zona-free oocytes induced granulosa cell apoptosis (Hakuno et al.,1996). Structural homology of Fas with TNF and low-affinity nerve growth factor receptor. Murine granulosa cells resistant to Fas-mediated apoptosis, but when co-treated with TNF and IFN or CX, apoptosis resulted. Note that human TNF did not repeat these results (Quirk et al.,1998).
NCBI Summary: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains a death domain. It has been shown to play a central role in the physiological regulation of programmed cell death, and has been implicated in the pathogenesis of various malignancies and diseases of the immune system. The interaction of this receptor with its ligand allows the formation of a death-inducing signaling complex that includes Fas-associated death domain protein (FADD), caspase 8, and caspase 10. The autoproteolytic processing of the caspases in the complex triggers a downstream caspase cascade, and leads to apoptosis. This receptor has been also shown to activate NF-kappaB, MAPK3/ERK1, and MAPK8/JNK, and is found to be involved in transducing the proliferating signals in normal diploid fibroblast and T cells. At least eight alternatively spliced transcript variants encoding seven distinct isoforms have been described. The isoforms lacking the transmembrane domain may negatively regulate the apoptosis mediated by the full length isoform. |
||||
General function | Receptor, Cell death/survival, Apoptosis | ||||
Comment | Fas is a cell surface receptor that, when engaged by Fas ligand or specific agonistic antibodies, triggers apoptosis (Quirk et al.,1997). Colocalization of Fas and Fas ligand in certain follicles intimately correlated with granulosa cell apoptosis; no Fas or FasL found in healthy follicles (Hakuno et al.,1996). | ||||
Cellular localization | Plasma membrane | ||||
Comment | Surface epithelial cells died in response Fas mAb (Quirk et al.,1997). | ||||
Ovarian function | Follicle atresia, Luteolysis | ||||
Comment | A time-course study by Mori et al. (1997) showed that Fas mRNA was positive in murine atretic follicles through day 0 and day 2 of PMSG stimulation and negative thereafter. Follicular atresia shown to be caused by apoptosis, and apoptosis associated with internucleosomal DNA fragmentation directly regulated by the Fas/FasL system (Mori et al.,1997). Abundant expression of Fas antigen in the regressing corpora lutea and atretic follicles suggests that the Fas antigen participates in luteal regression and follicular atresia through the apoptotic process. Expression of Fas in oocyte of primordial and primary follicles, followed by decrease in the Fas expression in the oocyte with the advance of follicular maturation suggests that the Fas antigen expression in the oocyte may play a role in follicular selection (Kondo et al., 1996). | ||||
Expression regulated by | FSH, LH | ||||
Comment | Addition of gonadotropins led to Fas, FasL, and p53 decrease and subsequent follicular growth; also, Fas and FasL found in granulosa cells of atretic follicles localized with apoptosis pattern induced by gonadotropin withdrawal (Kim et al.,1999). Fas antigen mRNA was detectable in cultured bovine granulosa and theca cells, and expression was increased by treatment with interferon-gamma but not tumor necrosis factor-alpha. Granulosa and theca cells were resistant to Fas-induced killing unless pretreated with interferon-gamma. Tumor necrosis factor-alpha had no effect on Fas-induced killing (Vickers et al., 2000). | ||||
Ovarian localization | Oocyte, Granulosa, Theca, Luteal cells | ||||
Comment | Fas/FasL system found to activate sphingomyelin-ceramide pathway in thecal/interstitial cells (Foghi et al.,1998). Cataldo NA, et al 2000 reported immunolocalization of Fas and Fas ligand in the ovaries of women with polycystic ovary syndrome relationship to apoptosis. Fas immunostaining was present in pre-antral follicle oocytes, some primary and secondary pre-antral follicle granulosa cells, and both granulosa and theca of antral follicles, Thecal staining persisted with advancing atresia, while granulosa staining declined, In antral follicles, abundant Fas-positive cells co-localized with scattered nuclei immunopositive for apoptosis. Ovarian vascular myocytes were strongly Fas-immunopositive. Fas-ligand immunostaining was present in pre-antral follicles in oocytes and variably in granulosa, In antral follicles, granulosa and thecal Fas ligand staining increased with advancing atresia, Normal control ovaries showed follicular Fas and Fas ligand staining patterns similar to those in PCOS, but vascular staining was less prominent. In one healthy follicle, Fas immunostaining was seen in the oocyte and weakly in mural granulosa and theca interna. | ||||
Follicle stages | Primordial, Primary, Secondary, Antral, Corpus luteum | ||||
Comment | Fas antigen staining in secondary and antral follicles showed stains only for the oocyte, while in preovulatory follicles, neither the oocyte nor the granulosa and theca cells were stained for the Fas antigen. In corpora lutea, Fas antigen staining became apparent in the granulosa lutein cells during early luteal phase and intensified during mid luteal phase, while the theca lutein cells became positive for the Fas antigen staining during the mid luteal phase. During the late luteal phase, the staining intensity of the Fas antigen in the regressing corpora lutea further increased. In atretic primordial and primary follicles, only degenerating oocyte showed the Fas antigen staining. By contrast, in atretic antral follicles, the Fas antigen staining was profound in the degenerating granulosa cells at the early stage of atresia, and at the mid stage of atresia it was intensified in the cell surface of the scattered granulosa cells and became apparent in the theca cells. At late stage of atresia Fas antigen remained only in hypertrophied theca cells (Kondo et al.,1996). However, Sakamaki et al.(1997) found Fas protein in granulosa and luteal cells but not on oocytes in ovary. Binding of FasL to Fas receptor linked to apoptosis during regression of CL (Roughton et al.,1999).Pru JK, et al 202 investigated soluble Fasl, (sFasL)-activated production of ceramide, a second messenger of the sphingomyelin pathway, and activation of p38(MAPK), a member of the MAPK family. sFasL activated the sphingomyelin pathway, as evidenced by a 2-fold increase (P < 0.05) in the production of ceramide. Pretreatment with imipramine (50 mum), an inhibitor of acid sphingomyelinase activity, attenuated (75%; P < 0.05) sFasL-induced ceramide production, suggesting that the increase in ceramide was par- tially the result of acid sphingomyelinase-mediated hydrolysis of sphingomyelin. Treatment of luteal cells with sFasL or a cell-permeable ceramide analog (C8) for 24-48 h resulted in a significant increase (P < 0.05) in apoptosis. Western blot analysis revealed that sFasL had little effect on the activation of p38(MAPK) in primary bovine luteal steroidogenic cells. Furthermore, pretreatment with the p38(MAPK) inhibitor SB203590 failed (P > 0.05) to inhibit sFasL- or C8-induced death. Although sFasL did not alter basal progesterone levels detected in the culture medium, C8 caused a significant increase (P < 0.05) in progesterone concentrations within the medium. Collectively, these data suggest that the role of FasL, in luteolysis may be to activate the stress-induced sphingomyelin pathway that, in turn, serves as a mediator of apoptosis. | ||||
Phenotypes | |||||
Mutations |
5 mutations
Species: human
Species: human
Species: human
Species: mouse
Species: mouse
|
||||
Genomic Region | show genomic region | ||||
Phenotypes and GWAS | show phenotypes and GWAS | ||||
Links |
|
created: | Dec. 3, 1999, midnight | by: |
Garnier email:
home page: |
last update: | April 15, 2015, 10:38 a.m. | by: | hsueh email: |
Click here to return to gene search form